1325-54-8|Direct Orange 39 - Shanghai Canbi Pharma Ltd.

Current Location
Home Products
detail

Direct Orange 39 | CAS:1325-54-8

Direct Orange 39

Name：Direct Orange 39
CAS：1325-54-8
Synonyms：C.I. 40215; Chlorantine Fast Orange 3GLL; Cuprofix Orange 2GL; Derma Fast Orange W-G; Dicorel Orange LGG; Diphenyl Fast Orange GL; Direct Fast Orange LGG
Molecular Formula：
Molecular Weight：
EINESC：215-397-8

Description

Properties

没有数据	没有数据

Safety

没有数据	没有数据

SDS

Source	SDS/MSDS Samples
没有数据	没有数据

Synthetic Route

Name	CAS

Articles

Peer-Reviewed Papers

Triflusal: a review of its use in cerebral infarction and myocardial infarction, and as thromboprophylaxis in atrial fibrillation.David Murdoch et al.Drugs, 66(5), 671-692 (2006-04-20) Triflusal: an antiplatelet drug with a neuroprotective effect?José Antonio González-Correa et al.Cardiovascular drug reviews, 24(1), 11-24 (2006-08-31) [The risk of hemorrhage in long-term use of aspirin and triflusal].J Alvarez Sabín et al.Revista de neurologia, 27(160), 951-955 (1999-02-10) Triflusal: an old drug in modern antiplatelet therapy. Review of its action, use, safety and effectiveness.Hector Anninos et al.Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese, 50(3), 199-207 (2009-05-26) Triflusal.W McNeely et al.Drugs, 55(6), 823-833 (1998-06-09) Triflusal for preventing serious vascular events in people at high risk.J Costa et al.The Cochrane database of systematic reviews, (3)(3), CD004296-CD004296 (2005-07-22)

Remarks

Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.

Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).

Name	CAS

Description

Properties

Safety

SDS

Related Products

Related News